Ex Parte Fuchs - Page 5



          Appeal No. 2005-0960                                                        
          Application No. 10/053,166                                                  

          nothing in the examiner’s rejection or in the disclosure of Fujii           
          which indicates that the combination of peroxide and Zn oxide (as           
          taught by Hert) is not effective.                                           
               Rather, the express teaching of Fujii relates to a                     
          preference for the combination of peroxide and crosslinking aids            
          which include liquid acrylates of the type here claimed (e.g.,              
          trimethylolpropane trimethacrylate and ethylene glycol                      
          dimethacrylate; see lines 28-32 on specification page 3).  More             
          specifically, Fujii teaches that, “[w]hen an organic peroxide               
          type crosslinking agent is used as a crosslinking agent, it is              
          preferred to use in combination a crosslinking aid such as . . .            
          trimethylolpropane trimethacrylate [and] ethylene glycol                    
          dimethacrylate” (sentence bridging pages 9-10; emphasis added).             
          For the reasons fully articulated by the examiner, this explicit            
          teaching of a preference by Fujii would have motivated an artisan           
          to replace the peroxide and zinc oxide combination of Hert’s                
          example 4 with the preferred combination of peroxide and, for               
          example, trimethylolpropane trimethacrylate preferred by Fujii.             
               In light of the foregoing, it is our ultimate determination            
          that the examiner has established a prima facie case of                     
          obviousness which the appellant has failed to successfully rebut            

                                          5                                           




Page:  Previous  1  2  3  4  5  6  7  Next 

Last modified: November 3, 2007